September 2020 Highlights.
September 2020 Highlights.
复制标题
2020 年 9 月亮点。
DOI:
10.1161/strokeaha.120.031895
复制
发表时间:
2020
期刊:
影响因子:
8.3
通讯作者:
Romero,Jose
中科院分区:
文献类型:
--
作者:
Romero,Jose
Agarwal et al conducted a retrospective study to characterize the brain magnetic resonance imaging (MRI) characteristics, and relation to clinical, laboratory, and functional outcomes among patients with coronavirus disease-19 (COVID-19) and critical illness. Patients were admitted to 3 centers in New York, between March and May 2020. Out of 4131 patients with COVID-19, 115 had a brain MRI. Of these, 35 (30.4%) patients had leukoencephalopathy and cerebral microbleeds (CMB), 47 (40.9%) had acute/chronic infarcts, hemorrhages, or other chronic findings, and 33 (28.7%) had normal MRI. Patients with cerebral leukoencephalopathy and CMB were younger, required longer ventilator support, had longer hospitalizations, were thrombocytopenic with lower nadir platelet counts, higher peak D-dimer and peak INR, and had worse coma scores. Brain MRI findings included leukoencephalopathy (85.5%), restricted diffusion (53.3%), CMB (71.5%), and both leukoencephalopathy and CMB (57%). Leukoencephalopathy was perirolandic in 80% and in 8 patients (33%) also showed restricted diffusion. Deep white matter restricted diffusion was also seen 33.3% of patients with leukoencephalopathy. Most CMB were lobar (60%) and diffusely distributed (40%). CMB were frequently seen diffusely in the corpus callosum (60%) and in some patients restricted to the splenium (16%). In minimally adjusted multivariate analysis, leukoencephalopathy and CMB were associated with ventilator days. These patients also had worse modified Rankin Scale scores at discharge. This study provides insight into the brain imaging findings observed in relation to COVID-19 infection and suggests that MRI markers are related to more severe illness and worse outcomes in critically ill patients with COVID-19. See p 2649.